Results 151 to 160 of about 82,989 (289)
Sustainable hydrogen production can be obtained from hydogen‐rich biomass‐derived organic molecules through Acceptorless Dehydrogenation (AD) reactions. Glycerol and sugars are available in large quantities from industry and can be successfully used as substrates in AD protocols, in the presence of tailored, selective, easily tunable and thermally ...
Sylwia Kostera, Luca Gonsalvi
wiley +1 more source
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley +1 more source
Fermentation of rare sugar kojibiose by the oral bacteria is slow yet bacteria specific [PDF]
Beerens, Koen +4 more
core
Valorisation potential of natural low HCT poplar mutants in catalytic fast pyrolysis [PDF]
Boerjan, Wout +5 more
core +2 more sources
METABOLISM OF CERTAIN RARE SUGARS
Florence Clarke +2 more
openaire +1 more source
Pss knockdown in the midgut causes growth retardation in Drosophila similar to that in human LMHD
Abstract Background Phosphatidylserine synthase (PSS), localized in the mitochondrial membrane, synthesizes phosphatidylserine. In humans, mutations in Pss lead to Lenz–Majewski hyperostotic dwarfism, a disorder affecting growth and development. The effects of Pss mutations on the growth of Drosophila melanogaster are not fully known. Hence, this study
Kwan‐Young Kim +4 more
wiley +1 more source
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li +12 more
wiley +1 more source
OUTLOOK FOR EMERGING TECHNOLOGIES IN SUGAR PROCESSING [PDF]
Agribusiness,
Clarke, Stephen J.
core +1 more source
The Standardization of Rare Sugars. [PDF]
openaire +1 more source
Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen +7 more
wiley +1 more source

